Llewellyn-Jones C G, Hill S L, Stockley R A
Lung Immunobiochemical Research Laboratory, General Hospital, Birmingham, UK.
Thorax. 1994 Mar;49(3):207-12. doi: 10.1136/thx.49.3.207.
Corticosteroids are widely used in the treatment of many inflammatory conditions but the exact mode of action on neutrophil function is uncertain. Fluticasone propionate is a new topically active synthetic steroid which can be measured in body fluids and which undergoes first pass metabolism.
The effects of fluticasone propionate on the function of neutrophils isolated from normal, healthy control subjects and on the chemotactic activity of sputum sol phase were assessed.
Preincubation of neutrophils with fluticasone propionate reduced the chemotactic response to 10(-8) mol/l F-Met-Leu-Phe (FMLP) and to a 1:5 dilution of sputum sol phase in a dose dependent manner. Furthermore, when fluticasone propionate was added to sputum from eight patients with stable chronic obstructive bronchitis the chemotactic activity of a 1:5 dilution of the sol phase fell from a mean (SE) value of 22.2 (1.21) cells/field to 19.6 (0.89), 17.1 (0.74), and 11.9 (0.6) cells field at 1 mumol/l, 10 mumol/l, and 100 mumol/l, respectively. In further experiments fluticasone propionate preincubated with neutrophils inhibited fibronectin degradation by resting cells and by cells stimulated by FMLP (15.2% inhibition of resting cells, 5.1% inhibition of stimulated cells with 1 mumol/l fluticasone propionate, 24% and 18.7% inhibition respectively at 100 mumol/l fluticasone propionate. Fluticasone propionate had no effect on generation of superoxide anion by resting or stimulated cells.
These results indicate that fluticasone propionate has a direct suppressive effect on several aspects of neutrophil function and may suggest a role for this agent in the modulation of neutrophil mediated damage to connective tissue.
皮质类固醇广泛用于多种炎症性疾病的治疗,但对中性粒细胞功能的确切作用方式尚不确定。丙酸氟替卡松是一种新的具有局部活性的合成类固醇,可在体液中检测到,且经历首过代谢。
评估了丙酸氟替卡松对从正常健康对照受试者分离的中性粒细胞功能以及痰液相趋化活性的影响。
中性粒细胞与丙酸氟替卡松预孵育后,对10(-8)mol/l 甲酰甲硫氨酸-亮氨酸-苯丙氨酸(FMLP)和痰液相1:5稀释液的趋化反应呈剂量依赖性降低。此外,当将丙酸氟替卡松添加到8例稳定期慢性阻塞性支气管炎患者的痰液中时,液相1:5稀释液的趋化活性从平均(标准误)值22.2(1.21)个细胞/视野分别降至1μmol/l、10μmol/l和100μmol/l时的19.6(0.89)、17.1(0.74)和11.9(0.6)个细胞/视野。在进一步的实验中,与中性粒细胞预孵育的丙酸氟替卡松抑制了静息细胞和受FMLP刺激细胞的纤连蛋白降解(1μmol/l丙酸氟替卡松对静息细胞的抑制率为15.2%,对刺激细胞的抑制率为5.1%;100μmol/l丙酸氟替卡松时分别为24%和18.7%)。丙酸氟替卡松对静息或刺激细胞产生超氧阴离子没有影响。
这些结果表明,丙酸氟替卡松对中性粒细胞功能的多个方面具有直接抑制作用,可能提示该药物在调节中性粒细胞介导的结缔组织损伤中发挥作用。